DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

company name or ticker

3 Under-the-Radar Biotech Stocks You Need to Watch in 2014

Nektar Therapeutics, Omeros, and Spectrum Pharmaceuticals all face off with regulators in key decision dates for their developmental drugs later this year

Biotech Stock 'Hate' Mailbag: Readers Riot Over Galena, Prana

Is Spectrum Pharmaceuticals, Inc. Blazing the Comeback Trail?

Spectrum Pharmaceuticals has been one of the rare losers in the biopharma sector. That trend may be set to change, however, as the company has set itself up for long-term growth.

FDA to Review Spectrum Pharma' Beleodaq - Analyst Blog

SPPI Makes Notable Cross Below Critical Moving Average

Is A Short Squeeze Ahead for Spectrum Pharma (SPPI)? - Tale of the Tape

Is A Short Squeeze Ahead for Spectrum Pharma (SPPI)? - Tale of the Tape

Can the Rally in Spectrum Pharmaceuticals (SPPI) Shares Continue? - Tale of the Tape

SPPI Crosses Below Key Moving Average Level

Why Thompson Creek Metals, Spectrum Pharmaceuticals, and FactSet Research Systems Tumbled Today

The stock markets moved modestly lower as investors wait for the Fed's decision Wednesday, but bad news sent Thompson Creek Metals down 10%, Spectrum Pharmaceuticals falling 9%, and FactSet Research Systems dropping 6%. What's behind the losses for these stocks? Find out here.

Mid-Afternoon Market Update: Markets Mixed as iRobot Surges

See More Articles...